Format

Send to

Choose Destination
See comment in PubMed Commons below
Annu Rev Med. 2014;65:367-83. doi: 10.1146/annurev-med-010813-102251. Epub 2013 Oct 23.

Transcatheter aortic valve replacement: game-changing innovation for patients with aortic stenosis.

Author information

1
Columbia University Medical Center, New York, New York 10032; email: kjharjai@geisinger.edu.

Abstract

Transcatheter aortic valve replacement (TAVR) is an emerging technology for the management of patients with severe aortic stenosis (AS). First reported in 2002, TAVR has made remarkable progress in the past decade with completion of major randomized clinical trials, multiple observational registries, and evolution of several new devices. This article is a brief introductory overview of the TAVR procedure, devices, trials and registries, and newer developments in the field.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center